Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
COCP compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
COCP
Cocrystal Pharma, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
COCP
Cocrystal Pharma, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
COCP: latest quarter is a loss; flow not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
COCP, solid
LLY, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only COCP
0
None
Shared
0
No disclosed counterparties: COCP.
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
25 more · LLY chain
›
Role chip = supplier or customer
Source: SEC EDGAR
COCP
Cocrystal Pharma, Inc.
Change
1.07
▼
−0.11%
· post 1.03
· delayed
Mkt cap
$20.6M
Revenue
$105,000
Q2 FY26
Revenue
—
LLY
ELI Lilly & Co
Change
1,417.89
▲
+0.60%
· post 1,417.00
· delayed
After hours
Nov 4 '26
delayed
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
After hours
Nov 4 '26
delayed
COCP
Cocrystal Pharma, Inc.
vs
LLY
ELI Lilly & Co
1.07
▼
−0.11%
post 1.03
delayed
Price
1,417.89
▲
+0.60%
post 1,417.00
delayed
$20.6M
Mkt cap
$1.3T
Q2 FY26
$105,000
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
COCP
1.07
▼
−0.11%
vs
LLY
1,417.89
▲
+0.60%
After hours
Nov 4 '26
delayed